Derek C. Dashti, Ms, PhD, MBA
About Derek C. Dashti, Ms, PhD, MBA
Derek C. Dashti is a Senior R&D Scientist and the Founder, Inventor, and CEO of D&P Bioinnovations, with a strong background in bioengineering and executive leadership. He specializes in tissue engineering and regenerative medicine, focusing on translating research into clinical applications.
Work at Pinnacle Transplant
Derek C. Dashti serves as a Senior Research and Development Scientist at Pinnacle Transplant Technologies LLC. He has been in this role since 2023. In this position, he leads projects that focus on tissue engineering and regenerative medicine. His work is centered on translating research-stage biotech technologies into clinical applications, emphasizing the importance of bridging the gap between academic research and industry practices.
Education and Expertise
Derek C. Dashti has an extensive educational background in bioengineering and business. He earned a Bachelor of Science in Bioengineering and Biomedical Engineering from the University of California, Berkeley, from 2005 to 2009. He then obtained a Master's degree in Bioengineering - Translational Medicine from the University of California, Berkeley, in 2011. He completed his Doctor of Philosophy (PhD) in Bioinnovation - IGERT/Bioengineering at Tulane University from 2012 to 2017. Additionally, he achieved an Executive MBA from the University of California, Irvine - The Paul Merage School of Business, from 2020 to 2022.
Background
Derek C. Dashti has a diverse professional background that includes significant experience in both academia and industry. He worked as a PhD Academic Intern at the U.S. FDA in 2013 for one month. Since 2015, he has been the Founder, Inventor, and CEO of D&P Bioinnovations, located in the Greater San Diego Area. His career reflects a strong commitment to advancing biotech innovations through a combination of scientific expertise and executive leadership.
Achievements
Derek C. Dashti has made notable contributions to the field of bioengineering and regenerative medicine. His leadership in projects at Pinnacle Transplant Technologies focuses on the development of novel technologies aimed at improving clinical applications. His academic achievements, including a PhD and an Executive MBA, complement his role in facilitating the translation of research into practical solutions in the biotech industry.